Lv11
10 积分 2025-12-15 加入
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
6小时前
已完结
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
8小时前
已完结
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
9小时前
已完结
Single coadministration of erythrocyte-uricase conjugate and immunosuppressant induces durable immune tolerance for gout therapy
15天前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
18天前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
1个月前
已完结
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
1个月前
已完结
A high-throughput selection system for fast-acting covalent protein drugs
1个月前
已完结
Sympathetic-epithelial crosstalk governs tissue-resident memory T cell immunosurveillance in the skin
1个月前
已完结
Rescuing dendritic cell interstitial motility sustains antitumour immunity
1个月前
已完结
皖公网安备34019202002308
